MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rec.2023.07.001

Медицинская библиотека · Revista espanola de cardiologia (English ed.) · 2023

Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial.

Verardi Filippo Maria, Bujak Kamil, Tolomeo Paolo, Gómez-Lara Josep, Jiménez-Díaz Víctor, Jiménez Marcelo, Jiménez-Quevedo Pilar, Diletti Roberto, Bordes Pascual, Campo Gianluca, Silvestro Antonio, Maristany Jaume, Flores Xacobe, de Miguel-Castro Antonio, Íñiguez Andrés, Ielasi Alfonso, Tespili Maurizio, Lenzen Mattie, Gonzalo Nieves, Tebaldi Matteo, Biscaglia Simone, Vidal-Cales Pablo, Ortega-Paz Luis, Romaguera Rafael, Gómez-Hospital Joan Antoni, Serruys Patrick W, Sabaté Manel, Brugaletta Salvatore

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

INTRODUCTION AND

OBJECTIVES

After ST-segment myocardial infarction (STEMI), the impact of different adverse events on prognosis remains unknown. We aimed to assess very long-term predictors of patient-oriented composite endpoints (POCE) and investigate whether the occurrence of target vessel failure (TVF) vs a non-TVF event as the first event could potentially influence subsequent outcomes.

METHODS

The EXAMINATION-EXTEND trial randomized STEMI patients to receive either an everolimus-eluting stent or a bare-metal stent. The follow-up period was 10 years. Predictors of POCE (a composite of all-cause death, any myocardial infarction, or any revascularization) were evaluated in the overall study population. The patients were stratified based on the type of first event (TVF-first vs non-TVF-first) and were compared in terms of subsequent POCE. TVF was defined as a composite of cardiac death, TV myocardial infarction, or TV revascularization.

RESULTS

Out of the 1498 enrolled patients, 529 (35.3%) experienced a POCE during the 10-year follow-up. Independent predictors of POCE were age, diabetes mellitus, previous myocardial infarction, peripheral arterial disease, and multivessel coronary disease. The first event was a TVF in 296 patients and was a non-TVF in 233 patients. No significant differences were observed between TVF-first and non-TVF-first patients in terms of subsequent POCE (21.7% vs 39.3%, time ratio 1.79; 95%CI, 0.87-3.67;P=.12) or its individual components.

CONCLUSIONS

At the 10-year follow-up, approximately one-third of STEMI patients had experienced at least 1 POCE. Independent predictors of these events were age, diabetes, and more extensive atherosclerotic disease. The occurrence of a TVF or a non-TVF as the first event did not seem to influence subsequent outcomes.

TRIAL REGISTRATION NUMBER: NCT04462315.

Для цитирования: Verardi Filippo Maria, Bujak Kamil, Tolomeo Paolo, Gómez-Lara Josep, Jiménez-Díaz Víctor, Jiménez Marcelo, Jiménez-Quevedo Pilar, Diletti Roberto, Bordes Pascual, Campo Gianluca, Silvestro Antonio, Maristany Jaume, Flores Xacobe, de Miguel-Castro Antonio, Íñiguez Andrés, Ielasi Alfonso, Tespili Maurizio, Lenzen Mattie, Gonzalo Nieves, Tebaldi Matteo, Biscaglia Simone, Vidal-Cales Pablo, Ortega-Paz Luis, Romaguera Rafael, Gómez-Hospital Joan Antoni, Serruys Patrick W, Sabaté Manel, Brugaletta Salvatore. Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial.. Revista espanola de cardiologia (English ed.). 2023. DOI: 10.1016/j.rec.2023.07.001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.